293A (human embryonic kidney cells) resuscitation, passage and cryopreservation protocol [identified by STR]

293A (human embryonic kidney cells) [identified by STR]

Specifications: 1 × 106 cells / T25 flask

Cell name

293A (human embryonic kidney cells)

species

people

Age (gender)

fetus

Organizational source

kidney

Growth characteristics

Sticking

Cell morphology

Epithelial cell-like

Growth medium

DMEM high sugar +10% FBS+1% P/S

Culture conditions

Gas phase: air, 95%; CO 2 , 5%

Temperature: 37 ° C

one,   recovery
1. Remove the cryotube from the liquid nitrogen and immediately put it into a 37 ° C water bath and shake it gently. After the liquid has melted (about 1-1.5 minutes), take out the alcohol and put it on the ultra-clean workbench.
2. Aspirate the above cell suspension into a 15 ml centrifuge tube containing 10 ml of medium (wash the cryotube with medium and wash the cells adhering to the wall) and centrifuge at 1000 rpm for 5 minutes.
3. Pour off the supernatant and add 1 ml of medium to suspend the cells. The cells in the culture dish were evenly distributed by sucking them into a 10 cm culture dish containing 10 ml of the medium and gently shaking them.
4. Mark the cell type and date, the name of the culture person, etc., put it in a CO2 incubator, and change the medium after the cells are attached.
5. Change the medium once every 3 days.
two,   pass on
1. Passage should be carried out when the cell coverage in the culture dish reaches 80%-90%.
2. Aspirate the original medium.
3. Add appropriate trypsin (can cover the cells) and digest for 1-2 minutes.
4. After the cells are rounded, add an equal volume of serum-containing medium to stop digestion.
5. Blow the cells with a pipette and suspend the cells.
6. Pipe the cells into a 15 ml centrifuge tube and centrifuge at 1000 rpm for 5 minutes.
7. Pour off the supernatant, add 1-2 ml of medium, and blow the cells.
8. Transfer the cells to several culture dishes depending on the cell type. Generally, there are 5 cancer cells and 3 normal cells. Continue to train.
three,   Cryopreservation
Digest the cells and centrifuge (ibid.). The cells were suspended in a prepared cryopreservation solution, dispensed into a sterile cryotube, and allowed to stand for a few minutes, indicating the cell type and the date of freezing. 4 ° C 30 min, -20 ° C 30 min, -80 ° C overnight, and then placed in liquid nitrogen irrigation.
Preparation of cryopreservation solution: 70% complete medium + 20% FBS + 10% DMSO. DMSO should be slowly added dropwise while shaking.
Pay attention to the aseptic operation!

Respiratory & Digestive System Drug

PRODUCT SPECIFICATION NORMAL PACKING
Cimitidine Tab. 0.2g 0.4g
Injection 200mg/2ml
1000`S/Tin
100`S/Box
Hyoscine Butylbromide Inj 20mg/Ml 10'sx10tray/Box
Lansoprazole Capsule 30mg 2x12/Blister/Box
Metoclopramide Injection 10mg/Ml 100amps/Box
Omeprazole Tablet 20mg
For Injection 40mg
2x12's/Blister/Box
10Vials/Box
Pantoprazole Capsule, Tablet 40mg 2x10`s/Box
Amlodipine Besylate Tablet 5mg ; 10mg
Atorvastatin Tablet 10mg, 20mg 10x10`s/Box
Fursemide Inj. 20mg/2ml 10'sx10tray/Bo
Irbesartan Tablet 150mg 10 x 10`s/Box
Lovastatin Tablet 40mg 12'sx1blister/Box
Nitroglycerine Aerosol 14g 200dose 1vial/Box
Simvastatin Film-coate Tab. 10mg; 20mg 10x10`s/Box
Tirofiban Injection 12.5mg/50ml 1`s/Box
Valsantan Tablet 80mg 10x10`s/Box

Ambroxol Injection,Cimetidine Injection,Xylometazoline Nasal Spray,Hyoscine Butylbromide Injection

NINGBO VOICE BIOCHEMIC CO. LTD , https://www.medicine-voice.com